Renato Bisonni

Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

Annamaria Ruzzo, Francesco Graziano, Fotios Loupakis et al. · Journal of Clinical Oncology · 2007 · 264 citations · Full text

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 250 citations · Full text

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy

Vincenzo Catalano, Fotios Loupakis, Francesco Graziano et al. · British Journal of Cancer · 2009 · 191 citations · Full text

Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer

Francesco Graziano, Annamaria Ruzzo, Fotios Loupakis et al. · Journal of Clinical Oncology · 2008 · 137 citations

Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy

Annamaria Ruzzo, Francesco Graziano, Kazuyuki Kawakami et al. · Journal of Clinical Oncology · 2006 · 134 citations · Full text